Radiotherapy compliance is maintained with hyprofractionation and concurrent cetuximab in locally advanced head and neck cancer

被引：8

作者：

Chan, Andrew ^{[1
]}

Teoh, Daien ^{[1
]}

Singhera, Paul ^{[1
]}

Hartley, Andrew ^{[1
]}

机构：

[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England

来源：

RADIOTHERAPY AND ONCOLOGY | 2009年 / 93卷 / 03期

关键词：

SQUAMOUS-CELL CARCINOMA;

D O I：

10.1016/j.radonc.2009.05.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：654 / 654

页数：1

共 4 条

[1] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].

Bonner, JA ;

Harari, PM ;

Giralt, J ;

Azarnia, N ;

Shin, DM ;

Cohen, RB ;

Jones, CU ;

Sur, R ;

Raben, D ;

Jassem, J ;

Ove, R ;

Kies, MS ;

Baselga, J ;

Youssoufian, H ;

Amellal, N ;

Rowinsky, EK ;

Ang, KK .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578

[2]

*NAT I HLTH CLIN E, 2008, CET TREATM LOC ADV S

[3] Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer [J].

Pryor, David I. ;

Porceddu, Sandro V. ;

Burmeister, Bryan H. ;

Guminski, Alex ;

Thomson, Damien B. ;

Shepherdson, Kristine ;

Poulsen, Michael .

RADIOTHERAPY AND ONCOLOGY, 2009, 90 (02) :172-176

[4] Hypofractionated accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck [J].

Sanghera, Paul ;

McConkey, Cris ;

Ho, Kean-Fatt ;

Glaholm, John ;

Hartley, Andrew .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05) :1342-1351

← 1 →